Subgroup Analyses in Nephrology Clinical Trials

Clinical Journal of the American Society of Nephrology - United States
doi 10.2215/cjn.04870512
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Subgroup Analyses of Randomized Clinical Trials in Heart Failure: Facts and Numbers

ESC heart failure
Cardiovascular MedicineCardiology
2016English

Subgroup Identification in Clinical Trials via the Predicted Individual Treatment Effect

PLoS ONE
Multidisciplinary
2018English

Subgroup Analyses in Randomised Controlled Trials: Quantifying the Risks of False-Positives and False-Negatives

Health Technology Assessment
MedicineHealth Policy
2001English

The Importance of “Shrinkage” in Subgroup Analyses

Annals of Emergency Medicine
Emergency Medicine
2010English

Multi-Targeted Antiangiogenic Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer: Meta-Analyses of 20 Randomized Controlled Trials and Subgroup Analyses

PLoS ONE
Multidisciplinary
2014English

Interpretation of Subgroup Analyses in Systematic Reviews: A Tutorial

Clinical Epidemiology and Global Health
EpidemiologyPublic HealthMicrobiologyEnvironmentalInfectious DiseasesOccupational Health
2019English

Clinical Excellence in Nephrology: Examples From the Published Literature

BMC Nephrology
Nephrology
2015English

OARSI Clinical Trials Recommendations: Hip Imaging in Clinical Trials in Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2015English

Three Simple Rules to Ensure Reasonably Credible Subgroup Analyses

British Medical Journal
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy